Genomics Market Size, Share, Trends and Forecast by Component, Application, Technology, End User, and Region, 2026-2034
The global genomics market size was valued at USD 43.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 127.2 Billion by 2034, exhibiting a CAGR of 12.26% from 2026-2034. North America currently dominates the market, holding a market share of 39.2% in 2025. The region benefits from substantial government investment in genomic research programs, a well-established healthcare and life sciences infrastructure, and the widespread integration of next-generation sequencing technologies into clinical diagnostics and precision medicine, along with strong biopharmaceutical research and development (R&D) activities, all contributing to the genomics market share.
The rising prevalence of chronic and genetic disorders worldwide is a significant factor propelling the growth of the genomics market. The growing adoption of precision medicine approaches, which rely on genomic data to tailor treatments to individual patient profiles, is further accelerating the demand for advanced genomic tools and services. Additionally, the declining cost of genome sequencing, driven by continuous technological advancements in next-generation sequencing platforms, is making genomic analysis more accessible across research institutions, hospitals, and diagnostic laboratories globally. The expanding applications of genomics in oncology, rare disease diagnostics, pharmacogenomics, and reproductive health are creating diverse revenue streams for market participants.
The United States is establishing itself as a major contributor to the global genomics market, supported by advanced healthcare infrastructure, strong diagnostic capabilities, and a dense network of academic medical centers engaged in leading genomic research. Federal funding continues to play a critical role in expanding precision medicine and population sequencing initiatives, strengthening integration of genomics into routine clinical care. This commitment is illustrated by the 2025 launch of BEACONS by Mass General Brigham and its partners, supported by a USD 14.4 Million NIH award, which planned to enroll up to 30,000 newborns across as many as 10 states to evaluate the feasibility and scalability of incorporating whole genome sequencing into public health newborn screening. Through such initiatives, the United States continues to advance clinical adoption models and reinforce its leadership position in the genomics market.
GENOMICS MARKET TRENDS:
Integration of AI in Genomic Drug Development
The growing application of AI in genomic analysis is accelerating drug discovery efficiency and improving target validation processes across the pharmaceutical sector. Companies are increasingly adopting AI driven platforms to analyze large scale genetic datasets, prioritize therapeutic targets, and refine clinical development strategies with greater precision. Reflecting this momentum, in 2025, Genomics launched Mystra, presented as the first AI enabled human genetics platform, built on more than 20,000 GWAS and trillions of integrated data points to enable rapid and scalable genetic analysis. Already adopted by major pharmaceutical companies under flexible service models, such platforms are strengthening R&D productivity and supporting higher clinical success rates, thereby driving market expansion.
Expansion of Advanced Genomic Diagnostic Infrastructure
The growing investment in specialized genomic centers across emerging economies is accelerating adoption of precision diagnostics and molecular testing services. Healthcare providers are strengthening laboratory capabilities, accreditation standards, and next generation sequencing capacity to meet the rising demand for oncology, reproductive health, neurology, and rare disease testing. Reflecting this trend, in 2026, Metropolis Healthcare launched its Centre of Genomics in India, integrating CAP accredited referral laboratories, multi-platform NGS systems, including Illumina’s NovaSeq X Series, and multidisciplinary expertise to deliver more than 220 validated genomic tests, with plans to expand beyond 500. Such developments are enhancing access to high quality genomic services and contributing to the market growth.
Growing Demand for Integrated Multi-omic Analysis Solutions
The increasing demand for comprehensive molecular profiling is driving adoption of integrated multi-omic sequencing technologies within research and clinical settings. Researchers and clinicians seek solutions that capture both genetic variation and epigenetic modifications in a single workflow to improve biological interpretation and disease characterization. Reflecting this shift, in 2025, Illumina launched its 5-base solution, enabling simultaneous detection of genomic variants and DNA methylation from a single sample using proprietary chemistry and updated DRAGEN algorithms. Compatible with NovaSeq and NextSeq platforms, the commercially available kits enhance scalability and operational efficiency, supporting expanded use of combined genome and epigenome analysis in precision medicine research.
GENOMICS MARKET INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the global genomics market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on component, application, technology, and end user.
Analysis by Component:
Analysis by Application:
Analysis by Technology:
Analysis by End User:
Regional Analysis:
KEY REGIONAL TAKEAWAYS:
UNITED STATES GENOMICS MARKET ANALYSIS
The United States remains the largest national genomics market in North America, supported by substantial federal research funding, advanced healthcare systems, and a mature pharmaceutical and biotechnology industry that actively integrates sequencing into drug discovery and clinical practice. Leadership in genomic innovation is reinforced by the presence of major sequencing technology developers, leading academic research centers, and an expanding network of certified clinical genomics laboratories. The growing use of whole genome sequencing in neonatal screening, oncology diagnostics, and pharmacogenomics continues to widen commercial and clinical applications. Reflecting this sustained demand, in 2024 Complete Genomics opened a 10,115 square foot manufacturing facility at its San Jose headquarters, establishing its first United States based supply chain for DNBSEQ sequencing platforms and supporting research, engineering, and ISO compliant manufacturing to improve delivery timelines. Such investments strengthen domestic supply resilience while advancing the country’s position in next generation sequencing technologies. Such investments strengthen domestic supply resilience while advancing the country’s position in next generation sequencing technologies, offering a positive long term genomics market outlook.
EUROPE GENOMICS MARKET ANALYSIS
The Europe genomics market continues to evolve under the influence of large scale government funded sequencing programs and the steady integration of genomic testing into national healthcare systems. Public investment in population genomics, rare disease diagnostics, and cancer profiling is reinforcing the role of sequencing as a routine clinical tool rather than a purely research-based capability. This direction is illustrated by Genomics England’s 2025 launch of the “Genomics, Healthcare and You” nationwide engagement program, designed to inform a future study that will sequence 150,000 adult genomes for preventive healthcare research, with consultations across the public, underrepresented communities, and healthcare professionals on pharmacogenomics, risk communication, and long-term data use during 2025 and 2026. Insights from this process will guide study design and digital infrastructure development, further embedding genomics within mainstream European healthcare delivery and supporting sustained genomics market growth across the region.
ASIA-PACIFIC GENOMICS MARKET ANALYSIS
The Asia Pacific region is emerging as a vital market for genomics, supported by expanding healthcare infrastructure, rising public funding for precision medicine initiatives, and the presence of cost competitive local sequencing providers that are improving access to advanced genomic technologies. Governments across the region are prioritizing national genome programs and translational research to strengthen population health management and biotechnology innovation. This momentum is reflected in a 2025 Memorandum of Understanding between Illumina and the Okinawa Institute of Science and Technology to accelerate genomics innovation in Japan under a One World, One Health approach, combining next generation sequencing technologies with interdisciplinary research to advance human, animal, and environmental health, including marine conservation through environmental DNA sequencing, as well as talent development and industry academia collaboration.
LATIN AMERICA GENOMICS MARKET ANALYSIS
The Latin America genomics market is growing steadily, supported by stronger government backing and cross border research partnerships aimed at strengthening regional genomic capabilities. The growing recognition of the value of genomic medicine in improving diagnosis, prevention, and population health outcomes is accelerating investment in sequencing infrastructure, national biobanks, and bioinformatics training. Reflecting this momentum, in 2025, Tecnol?gico de Monterrey announced that the oriGen Project achieved its target of collecting genetic samples from 100,000 individuals across 19 Mexican states, with exome sequencing planned for all participants and whole genome sequencing for 10,000 individuals, with initial results expected in 2026 to inform long term public health research.
MIDDLE EAST AND AFRICA GENOMICS MARKET ANALYSIS
The Middle East and Africa genomics market is at an early but promising stage of development, driven by increasing government investments in precision medicine infrastructure and population-scale genomic research programs. Several countries in the region are launching ambitious genome sequencing initiatives to address local healthcare challenges and build indigenous genomic databases. For instance, in 2025, a joint venture secured a contract from NUPCO in Saudi Arabia for large-scale genetic testing services, expanding precision medicine capabilities across 83 public hospitals throughout the kingdom. The growing adoption of genomic testing for infectious disease surveillance and cancer diagnostics is creating new opportunities for market expansion across the region.
COMPETITIVE LANDSCAPE:
The global genomics market is characterized by intense competition among established technology leaders, specialized diagnostic companies, and emerging innovators. Key market participants are pursuing strategies centered on technological differentiation, product portfolio expansion, and strategic partnerships to strengthen their competitive positions. Companies are investing substantially in R&D to advance sequencing accuracy, reduce per-genome costs, and develop integrated bioinformatics solutions that streamline laboratory workflows. The trend of consolidation through mergers and acquisitions (M&A) is enabling larger players to expand their capabilities across the genomics value chain, while strategic collaborations between technology providers and healthcare institutions are accelerating the clinical translation of genomic discoveries. The growing emphasis on AI-powered analytical tools, cloud-based data management platforms, and automated sample preparation systems reflects the evolving competitive dynamics within the industry.
The report provides a comprehensive analysis of the competitive landscape in the genomics market with detailed profiles of all major companies, including:
1. How big is the genomics market?
2. What is the future outlook of the genomics market?
3. What are the key factors driving the genomics market?
4. Which region accounts for the largest genomics market share?
5. Which are the leading companies in the global genomics market?
The rising prevalence of chronic and genetic disorders worldwide is a significant factor propelling the growth of the genomics market. The growing adoption of precision medicine approaches, which rely on genomic data to tailor treatments to individual patient profiles, is further accelerating the demand for advanced genomic tools and services. Additionally, the declining cost of genome sequencing, driven by continuous technological advancements in next-generation sequencing platforms, is making genomic analysis more accessible across research institutions, hospitals, and diagnostic laboratories globally. The expanding applications of genomics in oncology, rare disease diagnostics, pharmacogenomics, and reproductive health are creating diverse revenue streams for market participants.
The United States is establishing itself as a major contributor to the global genomics market, supported by advanced healthcare infrastructure, strong diagnostic capabilities, and a dense network of academic medical centers engaged in leading genomic research. Federal funding continues to play a critical role in expanding precision medicine and population sequencing initiatives, strengthening integration of genomics into routine clinical care. This commitment is illustrated by the 2025 launch of BEACONS by Mass General Brigham and its partners, supported by a USD 14.4 Million NIH award, which planned to enroll up to 30,000 newborns across as many as 10 states to evaluate the feasibility and scalability of incorporating whole genome sequencing into public health newborn screening. Through such initiatives, the United States continues to advance clinical adoption models and reinforce its leadership position in the genomics market.
GENOMICS MARKET TRENDS:
Integration of AI in Genomic Drug Development
The growing application of AI in genomic analysis is accelerating drug discovery efficiency and improving target validation processes across the pharmaceutical sector. Companies are increasingly adopting AI driven platforms to analyze large scale genetic datasets, prioritize therapeutic targets, and refine clinical development strategies with greater precision. Reflecting this momentum, in 2025, Genomics launched Mystra, presented as the first AI enabled human genetics platform, built on more than 20,000 GWAS and trillions of integrated data points to enable rapid and scalable genetic analysis. Already adopted by major pharmaceutical companies under flexible service models, such platforms are strengthening R&D productivity and supporting higher clinical success rates, thereby driving market expansion.
Expansion of Advanced Genomic Diagnostic Infrastructure
The growing investment in specialized genomic centers across emerging economies is accelerating adoption of precision diagnostics and molecular testing services. Healthcare providers are strengthening laboratory capabilities, accreditation standards, and next generation sequencing capacity to meet the rising demand for oncology, reproductive health, neurology, and rare disease testing. Reflecting this trend, in 2026, Metropolis Healthcare launched its Centre of Genomics in India, integrating CAP accredited referral laboratories, multi-platform NGS systems, including Illumina’s NovaSeq X Series, and multidisciplinary expertise to deliver more than 220 validated genomic tests, with plans to expand beyond 500. Such developments are enhancing access to high quality genomic services and contributing to the market growth.
Growing Demand for Integrated Multi-omic Analysis Solutions
The increasing demand for comprehensive molecular profiling is driving adoption of integrated multi-omic sequencing technologies within research and clinical settings. Researchers and clinicians seek solutions that capture both genetic variation and epigenetic modifications in a single workflow to improve biological interpretation and disease characterization. Reflecting this shift, in 2025, Illumina launched its 5-base solution, enabling simultaneous detection of genomic variants and DNA methylation from a single sample using proprietary chemistry and updated DRAGEN algorithms. Compatible with NovaSeq and NextSeq platforms, the commercially available kits enhance scalability and operational efficiency, supporting expanded use of combined genome and epigenome analysis in precision medicine research.
GENOMICS MARKET INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the global genomics market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on component, application, technology, and end user.
Analysis by Component:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Analysis by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
Analysis by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
Analysis by End User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Regional Analysis:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
KEY REGIONAL TAKEAWAYS:
UNITED STATES GENOMICS MARKET ANALYSIS
The United States remains the largest national genomics market in North America, supported by substantial federal research funding, advanced healthcare systems, and a mature pharmaceutical and biotechnology industry that actively integrates sequencing into drug discovery and clinical practice. Leadership in genomic innovation is reinforced by the presence of major sequencing technology developers, leading academic research centers, and an expanding network of certified clinical genomics laboratories. The growing use of whole genome sequencing in neonatal screening, oncology diagnostics, and pharmacogenomics continues to widen commercial and clinical applications. Reflecting this sustained demand, in 2024 Complete Genomics opened a 10,115 square foot manufacturing facility at its San Jose headquarters, establishing its first United States based supply chain for DNBSEQ sequencing platforms and supporting research, engineering, and ISO compliant manufacturing to improve delivery timelines. Such investments strengthen domestic supply resilience while advancing the country’s position in next generation sequencing technologies. Such investments strengthen domestic supply resilience while advancing the country’s position in next generation sequencing technologies, offering a positive long term genomics market outlook.
EUROPE GENOMICS MARKET ANALYSIS
The Europe genomics market continues to evolve under the influence of large scale government funded sequencing programs and the steady integration of genomic testing into national healthcare systems. Public investment in population genomics, rare disease diagnostics, and cancer profiling is reinforcing the role of sequencing as a routine clinical tool rather than a purely research-based capability. This direction is illustrated by Genomics England’s 2025 launch of the “Genomics, Healthcare and You” nationwide engagement program, designed to inform a future study that will sequence 150,000 adult genomes for preventive healthcare research, with consultations across the public, underrepresented communities, and healthcare professionals on pharmacogenomics, risk communication, and long-term data use during 2025 and 2026. Insights from this process will guide study design and digital infrastructure development, further embedding genomics within mainstream European healthcare delivery and supporting sustained genomics market growth across the region.
ASIA-PACIFIC GENOMICS MARKET ANALYSIS
The Asia Pacific region is emerging as a vital market for genomics, supported by expanding healthcare infrastructure, rising public funding for precision medicine initiatives, and the presence of cost competitive local sequencing providers that are improving access to advanced genomic technologies. Governments across the region are prioritizing national genome programs and translational research to strengthen population health management and biotechnology innovation. This momentum is reflected in a 2025 Memorandum of Understanding between Illumina and the Okinawa Institute of Science and Technology to accelerate genomics innovation in Japan under a One World, One Health approach, combining next generation sequencing technologies with interdisciplinary research to advance human, animal, and environmental health, including marine conservation through environmental DNA sequencing, as well as talent development and industry academia collaboration.
LATIN AMERICA GENOMICS MARKET ANALYSIS
The Latin America genomics market is growing steadily, supported by stronger government backing and cross border research partnerships aimed at strengthening regional genomic capabilities. The growing recognition of the value of genomic medicine in improving diagnosis, prevention, and population health outcomes is accelerating investment in sequencing infrastructure, national biobanks, and bioinformatics training. Reflecting this momentum, in 2025, Tecnol?gico de Monterrey announced that the oriGen Project achieved its target of collecting genetic samples from 100,000 individuals across 19 Mexican states, with exome sequencing planned for all participants and whole genome sequencing for 10,000 individuals, with initial results expected in 2026 to inform long term public health research.
MIDDLE EAST AND AFRICA GENOMICS MARKET ANALYSIS
The Middle East and Africa genomics market is at an early but promising stage of development, driven by increasing government investments in precision medicine infrastructure and population-scale genomic research programs. Several countries in the region are launching ambitious genome sequencing initiatives to address local healthcare challenges and build indigenous genomic databases. For instance, in 2025, a joint venture secured a contract from NUPCO in Saudi Arabia for large-scale genetic testing services, expanding precision medicine capabilities across 83 public hospitals throughout the kingdom. The growing adoption of genomic testing for infectious disease surveillance and cancer diagnostics is creating new opportunities for market expansion across the region.
COMPETITIVE LANDSCAPE:
The global genomics market is characterized by intense competition among established technology leaders, specialized diagnostic companies, and emerging innovators. Key market participants are pursuing strategies centered on technological differentiation, product portfolio expansion, and strategic partnerships to strengthen their competitive positions. Companies are investing substantially in R&D to advance sequencing accuracy, reduce per-genome costs, and develop integrated bioinformatics solutions that streamline laboratory workflows. The trend of consolidation through mergers and acquisitions (M&A) is enabling larger players to expand their capabilities across the genomics value chain, while strategic collaborations between technology providers and healthcare institutions are accelerating the clinical translation of genomic discoveries. The growing emphasis on AI-powered analytical tools, cloud-based data management platforms, and automated sample preparation systems reflects the evolving competitive dynamics within the industry.
The report provides a comprehensive analysis of the competitive landscape in the genomics market with detailed profiles of all major companies, including:
- 23andMe, Inc.
- Agilent Technologies, Inc.
- Bayer Aktiengesellschaft
- BGI Genomics Co. Ltd.
- Bio-RAD Laboratories Inc.
- Danaher Corporation
- Illumina Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc.
- Myriad Genetics Inc.
- Roche Holding AG
- Thermo Fisher Scientific Inc.
1. How big is the genomics market?
2. What is the future outlook of the genomics market?
3. What are the key factors driving the genomics market?
4. Which region accounts for the largest genomics market share?
5. Which are the leading companies in the global genomics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE INDICATORS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GENOMICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE INDICATORS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2025
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2025
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2025
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2025
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2025
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: China: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: India: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: France: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2025
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2025
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2025
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2025
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2025
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: China: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: India: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: France: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2020 & 2025
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
LIST OF FIGURES
Table 1: Global: Genomics Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2026-2034
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2026-2034
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players
Table 1: Global: Genomics Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2026-2034
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2026-2034
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players
